gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Peripheral Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, CW; Froehlich, JM; Lohr, HA; Pfyffer, M; Wentz, KU; Zollikofer, CL | 1 |
| Braunschweig, M; Froehlich, JM; Guignard, D; Szucs-Farkas, Z; Ulrich, M; Wuersten, HU; Wyss, S | 1 |
2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Comparison of Gd-BOPTA and Gd-DOTA for peripheral CE-MRA: a double-blind clinical study.
Topics: Contrast Media; Double-Blind Method; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Vascular Diseases; Prospective Studies | 2002 |
1.0-M gadobutrol versus 0.5-M gadoterate for peripheral magnetic resonance angiography: a prospective randomized controlled clinical trial.
Topics: Aged; Contrast Media; Female; Heterocyclic Compounds; Humans; Image Enhancement; Imaging, Three-Dimensional; Ischemia; Leg; Magnetic Resonance Angiography; Male; Observer Variation; Organometallic Compounds; Peripheral Vascular Diseases; Prospective Studies | 2008 |